Related Experiment Video
Updated: Jul 15, 2026
05:05
Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
Systemic mastocytoma associated with lymposarcoma in an aged cat
Summary
Systemic mastocytoma in a cat led to a duodenal ulcer after prednisone treatment. The cancer later caused enlarged lymph nodes, leading to euthanasia and necropsy findings of mastocytoma and lymphosarcoma.
Area of Science:
- Veterinary Medicine
- Oncology
- Internal Medicine
Background:
- Systemic mastocytoma is a rare neoplastic condition in felines.
- Diagnosis and treatment of feline mast cell tumors can be complex.
- Complications arising from treatment or disease progression require careful monitoring.
Purpose of the Study:
- To report a case of systemic mastocytoma in a feline patient.
- To describe the clinical course and complications associated with the disease and its treatment.
- To highlight the potential for concurrent or secondary malignancies.
Main Methods:
- A 16-year-old cat was diagnosed with systemic mastocytoma.
- Initial treatment involved prednisone.
- Clinical progression, complications, and necropsy findings were documented.
Main Results:
- Prednisone therapy was discontinued due to a duodenal ulcer after 11 months.
- Twenty months post-diagnosis, the cat developed dyspnea secondary to enlarged pharyngeal lymph nodes.
- Necropsy revealed systemic mastocytoma and lymphosarcoma.
Conclusions:
- Systemic mastocytoma can have a protracted course with significant complications.
- Gastrointestinal complications, such as ulcers, may arise during treatment.
- Concurrent lymphosarcoma was identified, suggesting potential for co-existing or sequential malignancies in feline oncology.